成人急性髓细胞白血病治疗的成本效益

目的 成人急性髓细胞白血病（AML）治疗费用昂贵,不仅是一个临床问题,也是一个社会经济问题.方法 从治疗效果,该文探讨了急性髓细胞白血病的治疗花费和不同治疗阶段的成本效益.结果 AML治疗期间院内花费是最大比例的治疗支出,接受干移植是白血病治疗中最重要的花费.在诱导期和巩固期治疗阶段,患者个人情况不同,不同的治疗方案选择,成本效益存在明显的差异,使用集落刺激因子后有助于减少总治疗支出.结论 AML对社会造成的的经济负担十分显著.研究人员需要更多的考察AML治疗与一个国家经济和社会发展水平的相关关系,以便促进医疗保障体系给AML患者带来更多的治疗实惠.

Analysis of Cost-effectiveness of Treatment in Adult Patients with Acute Myeloid Leukemia

Objective It was not only a clinical problem but also a socio- economic problem for Expensive treatment of adult patients with acute myeloid leukemia （AML）. Methods The study discussed the costs and cost - effectiveness in different periods of treatment according to treatment efficacy. Results The hospital costs were the largest proportion of the treatment expenses. Meanwhile it was the most important expenditure for receiving the stem cell transplantation. In the induction and consolidation therapy, there existed significant difference in costeffectiveness for different patients, and different treatment. It was contributed to decrease the total costs for receiving colony - stimulating factor. Conclusion AML caused significant economic burden for the whole society. The researchers should pay more attention to the relation between AML treatment and the socio - economic development. Further it made medical security system bring more treatment benefits to AML patients.